共 23 条
- [1] Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's DiseaseACS MEDICINAL CHEMISTRY LETTERS, 2019, 10 (04): : 469 - 474De Simone, AngelaLa Pietra, ValeriaBetari, NibalPetragnani, NicolaConte, MariarosariaDaniele, SimonaPietrobono, DeborahMartini, ClaudiaPetralla, SabrinaCasadei, RaffaellaDavani, LaraFrabetti, FlaviaRussomanno, PasqualeNovellino, EttoreMontanari, SerenaTumiatti, VincenzoBallerini, PatriziaSarno, FedericaNebbioso, AngelaAltucci, LuciaMonti, BarbaraAndrisano, VincenzaMilelli, Andrea
- [2] Dual BACE-1/GSK-3β Inhibitors to Combat Alzheimer's Disease A Focused ReviewCURRENT TOPICS IN MEDICINAL CHEMISTRY, 2017, 17 (31) : 3361 - 3369Rampa, AngelaGobbi, SilviaDi Martino, Rita Maria ConcettaBelluti, FedericaBisi, Alessandra
- [3] Computational and ADMET Predictions of Novel Compounds as Dual Inhibitors of BuChE and GSK-3β to Combat Alzheimer's DiseasePHARMACEUTICS, 2024, 16 (08)Londhe, Saurabh G.Walhekar, VinayakShenoy, MangalaKini, Suvarna G.Scotti, Marcus T.Scotti, LucianaKumar, Dileep
- [4] Dual GSK-3β/AChE Inhibitors as a New Strategy for Multitargeting Anti -Alzheimer's Disease Drug DiscoveryACS MEDICINAL CHEMISTRY LETTERS, 2018, 9 (03): : 171 - 176Jiang, Xue-YangChen, Ting-KaiZhou, Jun-TingHe, Si-YuYang, Hong-YuChen, YaoQu, WeiFeng, FengSun, Hao-Peng
- [5] Investigation of naphthofuran moiety as potential dual inhibitor against BACE-1 and GSK-3β: molecular dynamics simulations, binding energy, and network analysis to identify first-in-class dual inhibitors against Alzheimer's diseaseJOURNAL OF MOLECULAR MODELING, 2017, 23 (08)Kumar, AkhilSrivastava, GauravaSrivastava, SwatiVerma, SeemaNegi, Arvind S.Sharma, Ashok
- [6] Investigation of naphthofuran moiety as potential dual inhibitor against BACE-1 and GSK-3β: molecular dynamics simulations, binding energy, and network analysis to identify first-in-class dual inhibitors against Alzheimer’s diseaseJournal of Molecular Modeling, 2017, 23Akhil KumarGaurava SrivastavaSwati SrivastavaSeema VermaArvind S. NegiAshok Sharma
- [7] Discovery of novel harmine derivatives as GSK-3β/DYRK1A dual inhibitors for Alzheimer's disease treatmentARCHIV DER PHARMAZIE, 2024, 357 (02)Qiu, JingsongFeng, XianglingChen, HuanhuaLiu, WenwuLiu, WenjieWu, LimengGao, XudongLiu, YanfangHuang, YaoguangGong, HaoQi, YimingXu, ZihuaZhao, Qingchun
- [8] A First-in-Class Small-Molecule that Acts as a Dual Inhibitor of HDAC and PDE5 and that Rescues Hippocampal Synaptic Impairment in Alzheimer’s Disease MiceNeuropsychopharmacology, 2017, 42 : 524 - 539Mar Cuadrado-TejedorCarolina Garcia-BarrosoJuan A Sánchez-AriasObdulia RabalMarta Pérez-GonzálezSara MederosAna UgarteRafael FrancoVictor SeguraGertrudis PereaJulen OyarzabalAna Garcia-Osta
- [9] A First-in-Class Small-Molecule that Acts as a Dual Inhibitor of HDAC and PDE5 and that Rescues Hippocampal Synaptic Impairment in Alzheimer's Disease MiceNEUROPSYCHOPHARMACOLOGY, 2017, 42 (02) : 524 - 539Cuadrado-Tejedor, MarGarcia-Barroso, CarolinaSanchez-Arias, Juan A.Rabal, ObduliaPerez-Gonzalez, MartaMederos, SaraUgarte, AnaFranco, RafaelSegura, VictorPerea, GertrudisOyarzabal, JulenGarcia-Osta, Ana
- [10] MicroRNA-Based Multitarget Approach for Alzheimer's Disease: Discovery of the First-In-Class Dual Inhibitor of Acetylcholinesterase and MicroRNA-15b BiogenesisJOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (17) : 9695 - 9704Gabr, Moustafa T.Brogi, Simone